Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study

Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis

(2017) Bradley A. Gross et al.   JOURNAL OF NEUROSURGERY

Propranolol stops progressive multiple cerebral cavernoma in an adult patient

(2016) Matthias Reinhard et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data

(2016) Margaret A Horne et al.   LANCET NEUROLOGY

Natural history of cavernous malformation

(2016) Shervin Taslimi et al.   NEUROLOGY

Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage

(2016) Joseph M. Zabramski et al.   World Neurosurgery

Infantile Hemangiomas

(2016) Patricia Ann Laken   Advances in Neonatal Care

The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action

(2014) Y. Ji et al.   BRITISH JOURNAL OF DERMATOLOGY

Propranolol targets the contractility of infantile haemangioma-derived pericytes

(2014) D. Lee et al.   BRITISH JOURNAL OF DERMATOLOGY

Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol

(2014) Juliette Miquel et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Propranolol for Cerebral Cavernous Angiomatosis

(2013) Irene Berti et al.   CLINICAL PEDIATRICS

Treatment of infantile haemangiomas with atenolol: Comparison with a historical propranolol group

(2013) M. de Graaf et al.   Journal of Plastic Reconstructive and Aesthetic Surgery

Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies

(2013) Jacoba P Greving et al.   LANCET NEUROLOGY

Propranolol Accelerates Adipogenesis in Hemangioma Stem Cells and Causes Apoptosis of Hemangioma Endothelial Cells

(2013) Alvin Wong et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis

(2012) JESSICA STILES et al.   Experimental and Therapeutic Medicine

Atenolol: A promising alternative to propranolol for the treatment of hemangiomas

(2011) Martine F. Raphaël et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The natural history of intracranial cavernous malformations

(2011) Bradley A. Gross et al.   Neurosurgical Focus

Propranolol Treatment for a Giant Infantile Brain Cavernoma

(2010) Maria Moschovi et al.   JOURNAL OF CHILD NEUROLOGY

Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells

(2010) Sylvie Lamy et al.   VASCULAR PHARMACOLOGY

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion

(2009) Borhane Annabi et al.   PHARMACOLOGICAL RESEARCH

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE